Skip to main content

The expression of PADI4 in synovium of rheumatoid arthritis

Rheumatology International volume 29, pages 1411–1416 (2009)Cite this article

Abstract

PADI4 that catalyzes the conversion of peptidylarginine to citrulline is associated with rheumatoid arthritis in some populations. The current study investigated the expressions of PADI4 in synovial fluid of RA (n = 73), osteoarthritis (OA, n = 96) and ankylosing spondylitis (AS, n = 32) using ELISA and western blotting following immuno-precipitation (n = 6 for each diseases). The study also compared the mRNA level of PADI4 in the synovial membrane of RA with the levels in the samples of OA and AS (n = 6 for each diseases) using real time PCR. ELISA detected a higher level of PADI4 in SF of RA than in samples of OA and AS (P = 0.0001). The level of PADI4 was significantly correlated with the level of rheumatic factor (P = 0.015), but not with anti cyclic citrullinated peptide antibody (anti-CCP) in the RA fluids. Western blotting confirmed the expression of PADI4 in SF of RA. Quantitative PCR measured higher transcription of PADI4 in the synovial membrane of RA than in the samples of OA and AS. The results confirmed increased expression of PADI4 in synovium of RA.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Tarcsa E et al (1996) Protein unfolding by peptidylarginine deiminase substrate specificity and structural relationships of the natural substrates. J Biol Chem 271:30709–30716. doi:10.1074/jbc.271.48.30709

    PubMed  Article  CAS  Google Scholar 

  2. Utz PJ, Genovese MC, Robinson WH (2004) Unlocking the “PAD” lock on rheumatoid arthritis. Ann Rheum Dis 63:330–332. doi:10.1136/ard.2003.015990

    PubMed  Article  CAS  Google Scholar 

  3. Suzuki A et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395–402. doi:10.1038/ng1206

    PubMed  Article  CAS  Google Scholar 

  4. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54:90–96. doi:10.1002/art.21536

    PubMed  Article  CAS  Google Scholar 

  5. Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dorner T (2006) Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 8:R34. doi:10.1186/ar1889

    PubMed  Article  Google Scholar 

  6. Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA (2003) Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48:2489–2500. doi:10.1002/art.11229

    PubMed  Article  CAS  Google Scholar 

  7. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE (2005) Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 7:R458. doi:10.1186/ar1697

    PubMed  Article  CAS  Google Scholar 

  8. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K (2005) Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44:40–50. doi:10.1093/rheumatology/keh414

    Article  CAS  Google Scholar 

  9. Arnett FC, Edworthys Bloch DA et al (1987) ARA diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 30:17–19

    Google Scholar 

  10. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27:361–368. doi:10.1002/art.1780270401

    PubMed  Article  Google Scholar 

  11. Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K (2005) The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 44:293–298. doi:10.1093/rheumatology/keh473

    Article  CAS  Google Scholar 

  12. Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K (2005) Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford) 44:1374–1382. doi:10.1093/rheumatology/kei023

    Article  CAS  Google Scholar 

  13. Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63:373–381. doi:10.1136/ard.2003.012211

    PubMed  Article  CAS  Google Scholar 

  14. Caspi D, Anouk M, Golan I et al (2006) Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum 55:53–56. doi:10.1002/art.21691

    PubMed  Article  CAS  Google Scholar 

  15. Agrawal S, Misra R, Aggarwal A (2007) Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 26:201–204. doi:10.1007/s10067-006-0275-5

    PubMed  Article  Google Scholar 

  16. del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E (2006) Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 24:281–286

    Google Scholar 

  17. Arnason JA, Jónsson T, Brekkan A, Sigurjónsson K, Valdimarsson H (1987) Relation between bone erosions and rheumatoid factor isotypes. Ann Rheum Dis 46:380–384. doi:10.1136/ard.46.5.380

    PubMed  Article  CAS  Google Scholar 

  18. Greiner A, Plischke H, Kellner H, Gruber R (2005) Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 1050:295–303. doi:10.1196/annals.1313.031

    PubMed  Article  CAS  Google Scholar 

  19. De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F (2005) Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Ann Rheum Dis 64:299–302. doi:10.1136/ard.2004.023523

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The present study was supported by the National Natural Science Foundation of China (NTFC) (30671949), the Shandong Science and Technology Research Program (2007GG20002001, 2006GG2202050), the Shandong Scientific Instrument Equipment Promotion Transformation Project (2006GG1108097-41, 2007GG2TC02050) and the Leading Project of Medical Science of Shandong.

Author information

Affiliations

  1. Key Laboratory for Bio-drugs of Ministry of Health, Research Center for Medicinal Biotechnology, Shandong Academy of Medical Sciences, Jingshi Road 89, 250062, Jinan, Shandong, People’s Republic of China

    Xiaotian Chang, Yan Zhao & Youming Zhu

  2. Department of Arthrosurgery, Provincial Hospital of Shandong, Jinan, Shandong, People’s Republic of China

    Shui Sun

  3. Department of Rheumatology, Shandong Hospital of Labor Health and Occupational Disease Control, Jinan, Shandong, People’s Republic of China

    Yunzhong Zhang

Authors
  1. Xiaotian Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shui Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yunzhong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Youming Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaotian Chang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chang, X., Zhao, Y., Sun, S. et al. The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 29, 1411–1416 (2009). https://doi.org/10.1007/s00296-009-0870-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0870-2

Keywords

  • Rheumatoid arthritis
  • PADI4
  • Synovial fluid
  • Synovial membrane
  • RF
  • Anti-CCP